supported by“USTC Research Funds of the Double First-Class Initiative”(YD9990002027 to FY,YD9100002021 to PS);the National Natural Science Foundation of China(22207100 to FY,22277114,31971152 to PS,21825703 to CLT,22307113 to SLL);the National Key Research&Development Project,Ministry of Science and Technology the China(2022YFC3400500 to CLT);Postdoctoral Science Foundation(2022M713054 to FY);the Strategic Priority Research Program of Chinese Academy of Sciences(XDB37000000 to CLT);Anhui Provincial Natural Science Foundation(2108085J16 to PS);And the National Key R&D Program of China(2021YFA1200104 to SLL);supported by“the Fundamental Research Funds for the Central Universities”.
Somatostatin receptor 5(SSTR5)is highly expressed in ACTH-secreting pituitary adenomas and is an important drug target for the treatment of Cushing’s disease.Two cyclic SST analog peptides(pasireotide and octreotide)...